Skip to main content

Cancer Prevention

Cancer Prevention A recent letter in The Scientist recommended greater emphasis on cancer prevention, and outlined personal and societal regimens to enhance prevention.1 While these recommendations are laudable, they have been known for years, but have essentially not been implemented. In the United States, and increasingly in many other countries, an illness sub-economy has developed. It goes by the misnomer of 'health care.' A substantial and increasing share of gross domestic product is

Written byRonald Kostoff
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00

A recent letter in The Scientist recommended greater emphasis on cancer prevention, and outlined personal and societal regimens to enhance prevention.1 While these recommendations are laudable, they have been known for years, but have essentially not been implemented.

In the United States, and increasingly in many other countries, an illness sub-economy has developed. It goes by the misnomer of 'health care.' A substantial and increasing share of gross domestic product is devoted to all aspects of chronic illness and its supporting infrastructure, including:

As a first step, the healing communities (orthodox and alternative) need to reach consensus on the causes of, and preventive steps for, chronic illnesses of various types. This step is critical for credibility and eventual public acceptance. Many causes of cancer often take decades to identify and verify. Much of the data is 'soft.' While controlled experiments are possible with animal models over lengthy time periods, experience ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Published In

Related Topics

The Scientist October Digest cover
October 2026

Antarctica’s Blood Falls Teems With Mysterious Microbial Life

Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.

View this Issue
Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

Evaluating Blood Biomarkers for Alzheimer’s Disease Staging

​Beckman Coulter
Find better biologics faster with Stunner and the AI Developability Workcell

Find better biologics faster with Stunner and the AI Developability Workcell

Unchained Labs
An image of microcentrifuge tubes arranged within colorful laboratory racks.

Choose clarity. Choose speed. Choose MyMass™

Refeyn
Characterizing LNP Heterogeneity With Super-Resolution Imaging

Characterizing LNP Heterogeneity With Super-Resolution Imaging

Oni

Products

Stellaromics Logo

Stellaromics Expands Pyxa Adoption as Instruments are Installed at Leading Research Institutions Across the U.S. and EuropeStellaromics, Inc., the leader in 3D

A monoclonal antibody surrounded by immune cells and red blood cells

CellRaft AIR: Find the Right Antibody-Producing Cells Faster

Cell Microsystems
Maxwell® Rapid ccfDNA Kit

Maxwell® Rapid ccfDNA Kit: Automated Purification of ccfDNA in Under 30 Minutes

Promega
Leica Biosystems, Tempus, and Paige logos side by side, marking the addition of Paige digital pathology AI tools to the Aperio AI Store.

Oncology Researchers Gain AI Cancer Tools in One Platform